G
Guillermo Torre-Amione
Researcher at Baylor College of Medicine
Publications - 121
Citations - 8177
Guillermo Torre-Amione is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Heart failure & Transplantation. The author has an hindex of 41, co-authored 110 publications receiving 7843 citations. Previous affiliations of Guillermo Torre-Amione include Houston Methodist Hospital.
Papers
More filters
Journal ArticleDOI
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
Guillermo Torre-Amione,Samir R. Kapadia,Claude R. Benedict,Hakan Oral,James B. Young,Douglas L. Mann +5 more
TL;DR: Circulating levels of proinflammatory cytokines increase in patients as their functional heart failure classification deteriorates, and activation of the neurohumoral axis is unlikely to completely explain the elaboration of pro inflammatory cytokines in heart failure.
Journal ArticleDOI
Altered Titin Expression, Myocardial Stiffness, and Left Ventricular Function in Patients With Dilated Cardiomyopathy
Sherif F. Nagueh,Gopi Shah,Yiming Wu,Guillermo Torre-Amione,Nicholas M.P. King,Sunshine Lahmers,Christian C. Witt,Christian C. Witt,Katy Becker,Siegfried Labeit,Siegfried Labeit,Henk Granzier +11 more
TL;DR: Investigating titin expression in patients with end-stage heart failure resulting from nonischemic dilated cardiomyopathy found changes in titin isoform expression significantly impact diastolic filling by lowering myocardial stiffness and clinical correlations support the relevance of these changes for LV function.
Journal ArticleDOI
Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration.
Samir R. Kapadia,Joseph Lee,Guillermo Torre-Amione,Holly H. Birdsall,Tony S. Ma,Douglas L. Mann +5 more
TL;DR: This study shows for the first time that the adult mammalian myocardium synthesizes biologically active TNF alpha through stimulation with endotoxin.
Journal ArticleDOI
Cardiac Improvement During Mechanical Circulatory Support A Prospective Multicenter Study of the LVAD Working Group
Simon Maybaum,Donna Mancini,Steve Xydas,Randall C. Starling,Keith D. Aaronson,Francis D. Pagani,Leslie W. Miller,Kenneth B. Margulies,Susan McRee,O.H. Frazier,Guillermo Torre-Amione +10 more
TL;DR: Although cellular recovery and improvement in ventricular function are observed, the degree of clinical recovery is insufficient for device explantation in most patients with chronic heart failure.
Journal ArticleDOI
Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure: The VERITAS Randomized Controlled Trials
John J.V. McMurray,John R. Teerlink,Gadi Cotter,Robert C. Bourge,John G.F. Cleland,Guillaume Jondeau,Henry Krum,Marco Metra,Christopher M. O'Connor,John D. Parker,Guillermo Torre-Amione,Dirk J. van Veldhuisen,James Lewsey,Aline Frey,Maurizio Rainisio,Isaac Kobrin +15 more
TL;DR: The endothelin receptor antagonist tezosentan did not improve symptoms or clinical outcomes in patients with acute heart failure and was not associated with worse outcomes.